The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Glycosphingolipids—Nature, Function, and Pharmacological Modulation
Abstract
The discovery of the glycosphingolipids is generally attributed to Johan L. W. Thudichum, who in 1884 published on the chemical composition of the brain. In his studies he isolated several compounds from ethanolic brain extracts which he coined cerebrosides. He subjected one of these, phrenosin (now known as galactosylceramide), to acid hydrolysis, and this produced three distinct components. One he identified as a fatty acid and another proved to be an isomer of D‐glucose, which is now known as D‐galactose. The third component, with an “alkaloidal nature”, presented “many enigmas” to Thudichum, and therefore he named it sphingosine, after the mythological riddle of the Sphinx. Today, sphingolipids and their glycosidated derivatives are the subjects of intense study aimed at elucidating their role in the structural integrity of the cell membrane, their participation in recognition and signaling events, and in particular their involvement in pathological processes that are at the basis of human disease (for example, sphingolipidoses and diabetes type 2). This Review details some of the recent findings on the biosynthesis, function, and degradation of glycosphingolipids in man, with a focus on the glycosphingolipid glucosylceramide. Special attention is paid to the clinical relevance of compounds directed at interfering with the factors responsible for glycosphingolipid metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Membrane lipids: where they are and how they behave
van Meer, G., Voelker, D. R., & Feigenson, G. W. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2330 · Cited by 7,157
Principles of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333
CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997) · Science · doi:10.1126/science.278.5343.1626 · Cited by 2,400
Pathways of clathrin-independent endocytosis
Mayor, S., & Pagano, R. E. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2216 · Cited by 1,556
Direct observation of the nanoscale dynamics of membrane lipids in a living cell
Eggeling, C., Ringemann, C., Medda, R., Schwarzmann, G., Sandhoff, K., Polyakova, S., Belov, V. N., Hein, B., von Middendorff, C., Schönle, A., et al. (2009) · Nature · doi:10.1038/nature07596 · Cited by 1,520
LMSD: LIPID MAPS structure database
Sud, M., Fahy, E., Cotter, D., Brown, A., Dennis, E. A., Glass, C. K., Merrill, A. H., Murphy, R. C., Raetz, C. R. H., Russell, D. W., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl838 · Cited by 1,375
Barton, N. W., Brady, R. O., Dambrosia, J. M., Di Bisceglie, A. M., Doppelt, S. H., Hill, S. C., Mankin, H. J., Murray, G. J., Parker, R. I., Argoff, C. E., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105233242104 · Cited by 1,252
Holland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232
Biologically active sphingolipids in cancer pathogenesis and treatment
Ogretmen, B., & Hannun, Y. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1411 · Cited by 1,213
Lipid rafts: at a crossroad between cell biology and physics
Jacobson, K., Mouritsen, O. G., & Anderson, R. G. W. (2007) · Nature Cell Biology · doi:10.1038/ncb0107-7 · Cited by 1,102
Molecular machinery for non-vesicular trafficking of ceramide
Hanada, K., Kumagai, K., Yasuda, S., Miura, Y., Kawano, M., Fukasawa, M., & Nishijima, M. (2003) · Nature · doi:10.1038/nature02188 · Cited by 1,051
Asano, N., Nash, R. J., Molyneux, R. J., & Fleet, G. W. J. (2000) · Tetrahedron: Asymmetry · doi:10.1016/s0957-4166(00)00113-0 · Cited by 1,015
Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
Hakomori, S. (1996) · PubMed · Cited by 987
Lysosomal Glycosphingolipid Recognition by NKT Cells
Zhou, D., Mattner, J., Cantu, C., Schrantz, N., Yin, N., Gao, Y., Sagiv, Y., Hudspeth, K., Wu, Y.-P., Yamashita, T., et al. (2004) · Science · doi:10.1126/science.1103440 · Cited by 956
Helicobacter pylori SabA Adhesin in Persistent Infection and Chronic Inflammation
Mahdavi, J., Sondén, B., Hurtig, M., Olfat, F. O., Forsberg, L., Roche, N., Ångström, J., Larsson, T., Teneberg, S., Karlsson, K.-A., et al. (2002) · Science · doi:10.1126/science.1069076 · Cited by 932
Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.
Hollak, C. E., van Weely, S., van Oers, M. H., & Aerts, J. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117084 · Cited by 896
Self-citationUnger, R. H. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104057 · Cited by 875
Ceramides in insulin resistance and lipotoxicity
SUMMERS, S. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.002 · Cited by 848
The cell biology of lysosomal storage disorders
Futerman, A. H., & van Meer, G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1423 · Cited by 796
Lipid rafts: contentious only from simplistic standpoints
Hancock, J. F. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1925 · Cited by 788
Cox, T., Lachmann, R., Hollak, C., Aerts, J., van Weely, S., Hrebícek, M., Platt, F., Butters, T., Dwek, R., Moyses, C., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02161-9 · Cited by 744
Self-citationElevated globotriaosylsphingosine is a hallmark of Fabry disease
Aerts, J. M., Groener, J. E., Kuiper, S., Donker-Koopman, W. E., Strijland, A., Ottenhoff, R., van Roomen, C., Mirzaian, M., Wijburg, F. A., Linthorst, G. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712309105 · Cited by 731
Self-citationGlycosidase inhibitors: update and perspectives on practical use
Asano, N. (2003) · Glycobiology · doi:10.1093/glycob/cwg090 · Cited by 715
Bioactive sphingolipids: metabolism and function
Bartke, N., & Hannun, Y. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800080-jlr200 · Cited by 683
Sphingolipids—The Enigmatic Lipid Class: Biochemistry, Physiology, and Pathophysiology
Merrill, A. H., Schmelz, E.-M., Dillehay, D. L., Spiegel, S., Shayman, J. A., Schroeder, J. J., Riley, R. T., Voss, K. A., & Wang, E. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8029 · Cited by 643
SphK1 and SphK2, Sphingosine Kinase Isoenzymes with Opposing Functions in Sphingolipid Metabolism
Maceyka, M., Sankala, H., Hait, N. C., Le Stunff, H., Liu, H., Toman, R., Collier, C., Zhang, M., Satin, L. S., Merrill, A. H., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502207200 · Cited by 636
The sphingolipid salvage pathway in ceramide metabolism and signaling
Kitatani, K., Idkowiak-Baldys, J., & Hannun, Y. A. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2007.12.006 · Cited by 632
Fan, J.-Q., Ishii, S., Asano, N., & Suzuki, Y. (1999) · Nature Medicine · doi:10.1038/4801 · Cited by 614
Holland, W. L., & Summers, S. A. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0025 · Cited by 595
Schmitz-Peiffer, C., Craig, D. L., & Biden, T. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24202 · Cited by 592
Sphingolipids in Food and the Emerging Importance of Sphingolipids to Nutrition
Vesper, H., Schmelz, E.-M., Nikolova-Karakashian, M. N., Dillehay, D. L., Lynch, D. V., & Merrill, A. H. (1999) · The Journal of Nutrition · doi:10.1093/jn/129.7.1239 · Cited by 582
Lysosomal disorders: From storage to cellular damage
Ballabio, A., & Gieselmann, V. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.12.001 · Cited by 571
Zheng, W., Kollmeyer, J., Symolon, H., Momin, A., Munter, E., Wang, E., Kelly, S., Allegood, J. C., Liu, Y., Peng, Q., et al. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.08.009 · Cited by 560
LIMP-2 Is a Receptor for Lysosomal Mannose-6-Phosphate-Independent Targeting of β-Glucocerebrosidase
Reczek, D., Schwake, M., Schröder, J., Hughes, H., Blanz, J., Jin, X., Brondyk, W., Van Patten, S., Edmunds, T., & Saftig, P. (2007) · Cell · doi:10.1016/j.cell.2007.10.018 · Cited by 542
Enhanced insulin sensitivity in mice lacking ganglioside GM3
Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J. L., Werth, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0635898100 · Cited by 531
Diversity in cell surface sialic acid presentations: implications for biology and disease
Varki, N. M., & Varki, A. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700656 · Cited by 515
Svennerholm, L. (1964) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40231-7 · Cited by 514
A vital role for glycosphingolipid synthesis during development and differentiation
Yamashita, T., Wada, R., Sasaki, T., Deng, C., Bierfreund, U., Sandhoff, K., & Proia, R. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9142 · Cited by 505
Sawkar, A. R., Cheng, W.-C., Beutler, E., Wong, C.-H., Balch, W. E., & Kelly, J. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192582899 · Cited by 503
Pike, L. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800040-jlr200 · Cited by 493
Detergent-resistant membranes should not be identified with membrane rafts
Lichtenberg, D., Goñi, F. M., & Heerklotz, H. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.06.004 · Cited by 490
De Matteis, M. A., & Luini, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2378 · Cited by 483
Mañes, S., del Real, G., & Martínez-A, C. (2003) · Nature Reviews Immunology · doi:10.1038/nri1129 · Cited by 477
Kolter, T., & Sandhoff, K. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.122303.120013 · Cited by 464
N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis.
Platt, F. M., Neises, G. R., Dwek, R. A., & Butters, T. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37202-2 · Cited by 455
Grabowski, G. A., Barton, N. W., Pastores, G., Dambrosia, J. M., Banerjee, T. K., McKee, M. A., Parker, C., Schiffmann, R., Hill, S. C., & Brady, R. O. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-1-199501010-00005 · Cited by 446
Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling
Chalfant, C. E., & Spiegel, S. (2005) · Journal of Cell Science · doi:10.1242/jcs.02637 · Cited by 444
When Do Lasses (Longevity Assurance Genes) Become CerS (Ceramide Synthases)?
Pewzner-Jung, Y., Ben-Dor, S., & Futerman, A. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.r600010200 · Cited by 435
Pruett, S. T., Bushnev, A., Hagedorn, K., Adiga, M., Haynes, C. A., Sullards, M. C., Liotta, D. C., & Merrill, A. H. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800012-jlr200 · Cited by 433
Targeting glycosylation as a therapeutic approach
Dwek, R. A., Butters, T. D., Platt, F. M., & Zitzmann, N. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd708 · Cited by 420
Mechanisms and strategies to overcome multiple drug resistance in cancer
Ozben, T. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.02.020 · Cited by 406
Lipid overload and overflow: metabolic trauma and the metabolic syndrome
UNGER, R. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2003.09.008 · Cited by 401
Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide
D’Angelo, G., Polishchuk, E., Tullio, G. D., Santoro, M., Campli, A. D., Godi, A., West, G., Bielawski, J., Chuang, C.-C., van der Spoel, A. C., et al. (2007) · Nature · doi:10.1038/nature06097 · Cited by 398
Akiyama, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24834 · Cited by 396
Simpson, M. A., Cross, H., Proukakis, C., Priestman, D. A., Neville, D. C. A., Reinkensmeier, G., Wang, H., Wiznitzer, M., Gurtz, K., Verganelaki, A., et al. (2004) · Nature Genetics · doi:10.1038/ng1460 · Cited by 389
Kabayama, K., Sato, T., Saito, K., Loberto, N., Prinetti, A., Sonnino, S., Kinjo, M., Igarashi, Y., & Inokuchi, J.-I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703650104 · Cited by 388
Sphingolipids—Their Metabolic Pathways and the Pathobiochemistry of Neurodegenerative Diseases
Kolter, T., & Sandhoff, K. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990601)38:11<1532::aid-anie1532>3.0.co;2-u · Cited by 386
Carbohydrate mimetics-based glycosyltransferase inhibitors
Compain, P., & Martin, O. R. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00176-6 · Cited by 385
Sphingolipid metabolism diseases
Kolter, T., & Sandhoff, K. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.05.027 · Cited by 367
Chemical and Biological Approaches Synergize to Ameliorate Protein-Folding Diseases
Mu, T.-W., Ong, D. S. T., Wang, Y.-J., Balch, W. E., Yates, J. R., Segatori, L., & Kelly, J. W. (2008) · Cell · doi:10.1016/j.cell.2008.06.037 · Cited by 359
Ganglioside GM3 Participates in the Pathological Conditions of Insulin Resistance
Tagami, S., Inokuchi, J.-I., Kabayama, K., Yoshimura, H., Kitamura, F., Uemura, S., Ogawa, C., Ishii, A., Saito, M., Ohtsuka, Y., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m103705200 · Cited by 355
Iminosugars: From Synthesis to Therapeutic Applications
(2007) · Wiley eBooks · doi:10.1002/9780470517437 · Cited by 351
Inhibition of HIV replication by amino‐sugar derivatives
Fleet, G. W. J., Karpas, A., Dwek, R. A., Fellows, L. E., Tyms, A. S., Petursson, S., Namgoong, S. K., Ramsden, N. G., Smith, P. W., Son, J. C., et al. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80185-6 · Cited by 349
The metabolism and function of sphingolipids and glycosphingolipids
Lahiri, S., & Futerman, A. H. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7076-0 · Cited by 344
Boot, R. G., Verhoek, M., de Fost, M., Hollak, C. E. M., Maas, M., Bleijlevens, B., van Breemen, M. J., van Meurs, M., Boven, L. A., Laman, J. D., et al. (2004) · Blood · doi:10.1182/blood-2003-05-1612 · Cited by 334
Self-citationIminosugars-From Synthesis to Therapeutic Applications
Ranade, V. V. (2009) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e318172886d · Cited by 328
The ins and outs of sphingolipid synthesis
Futerman, A. H., & Riezman, H. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.04.006 · Cited by 328
Combinatorial Ganglioside Biosynthesis
Kolter, T., Proia, R. L., & Sandhoff, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200001200 · Cited by 322
Ariga, T., McDonald, M. P., & Yu, R. K. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800007-jlr200 · Cited by 318
Ichikawa, S., Sakiyama, H., Suzuki, G., Hidari, K. I., & Hirabayashi, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4638 · Cited by 315
Brady, R. O., Tallman, J. F., Johnson, W. G., Gal, A. E., Leahy, W. R., Quirk, J. M., & Dekaban, A. S. (1973) · New England Journal of Medicine · doi:10.1056/nejm197307052890103 · Cited by 312
Pharmacological Inhibition of Glucosylceramide Synthase Enhances Insulin Sensitivity
Aerts, J. M., Ottenhoff, R., Powlson, A. S., Grefhorst, A., van Eijk, M., Dubbelhuis, P. F., Aten, J., Kuipers, F., Serlie, M. J., Wennekes, T., et al. (2007) · Diabetes · doi:10.2337/db06-1619 · Cited by 301
Self-citationSPTLC1 is mutated in hereditary sensory neuropathy, type 1
Bejaoui, K., Wu, C., Scheffler, M. D., Haan, G., Ashby, P., Wu, L., de Jong, P., & Brown, R. H. (2001) · Nature Genetics · doi:10.1038/85817 · Cited by 292
Boven, L. A., van Meurs, M., Boot, R. G., Mehta, A. B., Boon, L., Aerts, J. M. F. G., & Laman, J. D. (2004) · American Journal of Clinical Pathology · doi:10.1309/bg5v-a8jr-dqh1-m7hn · Cited by 290
Self-citationX‐ray structure of human acid‐β‐glucosidase, the defective enzyme in Gaucher disease
Dvir, H., Harel, M., McCarthy, A. A., Toker, L., Silman, I., Futerman, A. H., & Sussman, J. L. (2003) · EMBO reports · doi:10.1038/sj.embor.embor873 · Cited by 278
Pre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis
Halter, D., Neumann, S., van Dijk, S. M., Wolthoorn, J., de Mazière, A. M., Vieira, O. V., Mattjus, P., Klumperman, J., van Meer, G., & Sprong, H. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200704091 · Cited by 269
Epidermal sphingolipids: Metabolism, function, and roles in skin disorders
Holleran, W. M., Takagi, Y., & Uchida, Y. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.08.039 · Cited by 266
Roseman, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100053200 · Cited by 265
Inokuchi, J., & Radin, N. S. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38673-9 · Cited by 251
Lipid Mediators of Insulin Resistance
Holland, W. L., Knotts, T. A., Chavez, J. A., Wang, L.-P., Hoehn, K. L., & Summers, S. A. (2007) · Nutrition Reviews · doi:10.1301/nr.2007.jun.s39-s46 · Cited by 249
A treatise on the chemical constitution of the brain.
(1963) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1963.03700230140039 · Cited by 248
Structure of acid β-glucosidase with pharmacological chaperone provides insight into Gaucher disease
Lieberman, R. L., Wustman, B. A., Huertas, P., Powe, A. C., Pine, C. W., Khanna, R., Schlossmacher, M. G., Ringe, D., & Petsko, G. A. (2007) · Nature Chemical Biology · doi:10.1038/nchembio850 · Cited by 245
Selective Caveolin-1–dependent Endocytosis of Glycosphingolipids
Singh, R. D., Puri, V., Valiyaveettil, J. T., Marks, D. L., Bittman, R., & Pagano, R. E. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-12-0809 · Cited by 242
Zhao, H., Przybylska, M., Wu, I.-H., Zhang, J., Siegel, C., Komarnitsky, S., Yew, N. S., & Cheng, S. H. (2007) · Diabetes · doi:10.2337/db06-0719 · Cited by 238
Cox, T. M., Aerts, J. M. F. G., Andria, G., Beck, M., Belmatoug, N., Bembi, B., Chertkoff, R., Vom Dahl, S., Elstein, D., Erikson, A., et al. (2003) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1025902113005 · Cited by 236
Self-citationIntracellular transport and metabolism of sphingomyelin
Koval, M., & Pagano, R. E. (1991) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(91)90184-j · Cited by 234
Principles of lysosomal membrane degradation
Schulze, H., Kolter, T., & Sandhoff, K. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.09.020 · Cited by 229
Hara, J., Higuchi, K., Okamoto, R., Kawashima, M., & Imokawa, G. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00072.x · Cited by 229
Porubsky, S., Speak, A. O., Luckow, B., Cerundolo, V., Platt, F. M., & Gröne, H.-J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611139104 · Cited by 226
Composition and Morphology of Epidermal Cyst Lipids
Wertz, P. W., Schwartzendruber, D. C., Madison, K. C., & Downing, D. T. (1987) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12471781 · Cited by 226
Mutation of β-glucosidase 2 causes glycolipid storage disease and impaired male fertility
Yildiz, Y., Matern, H., Thompson, B., Allegood, J. C., Warren, R. L., Ramirez, D. M. O., Hammer, R. E., Hamra, F. K., Matern, S., & Russell, D. W. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29224 · Cited by 222
Glucosylceramide synthase and glycosphingolipid synthesis
Ichikawa, S., & Hirabayashi, Y. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01249-5 · Cited by 219
Steet, R. A., Chung, S., Wustman, B., Powe, A., Do, H., & Kornfeld, S. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605928103 · Cited by 218
Sharma, D. K., Choudhury, A., Singh, R. D., Wheatley, C. L., Marks, D. L., & Pagano, R. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210457200 · Cited by 218
The cell biology of glycosphingolipids
DEGROOTE, S., WOLTHOORN, J., & VANMEER, G. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2004.03.007 · Cited by 217
Recent Advances in the Total Synthesis of Piperidine Azasugars
Pearson, M. S. M., Mathé‐Allainmat, M., Fargeas, V., & Lebreton, J. (2005) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200400823 · Cited by 217
Lipid Mediators of Insulin Resistance
Holland, W. L., Knotts, T. A., Chavez, J. A., Wang, L.-P., Hoehn, K. L., & Summers, S. A. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00327.x · Cited by 203
Generation and metabolism of bioactive sphingosine‐1‐phosphate
Stunff, H. L., Milstien, S., & Spiegel, S. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20097 · Cited by 201
The Spectrum of Parkinsonian Manifestations Associated With Glucocerebrosidase Mutations
Goker-Alpan, O., Lopez, G., Vithayathil, J., Davis, J., Hallett, M., & Sidransky, E. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.1353 · Cited by 199
Deoxynojirimycin: synthesis and biological activity
Hughes, A. B., & Rudge, A. J. (1994) · Natural Product Reports · doi:10.1039/np9941100135 · Cited by 197
Design, Synthesis and Biological Evaluation of Iminosugar-Based Glycosyltransferase Inhibitors
Compain, P., & Martin, O. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452474 · Cited by 195
Covalent inhibitors of glycosidases and their applications in biochemistry and biology
Rempel, B. P., & Withers, S. G. (2008) · Glycobiology · doi:10.1093/glycob/cwn041 · Cited by 193
Generation of Specific Deoxynojirimycin-type Inhibitors of the Non-lysosomal Glucosylceramidase
Overkleeft, H. S., Renkema, G. H., Neele, J., Vianello, P., Hung, I. O., Strijland, A., van der Burg, A. M., Koomen, G.-J., Pandit, U. K., & Aerts, J. M. F. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26522 · Cited by 186
Self-citationIdentification of the Non-lysosomal Glucosylceramidase as β-Glucosidase 2
Boot, R. G., Verhoek, M., Donker-Koopman, W., Strijland, A., van Marle, J., Overkleeft, H. S., Wennekes, T., & Aerts, J. M. F. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610544200 · Cited by 185
Self-citationBiosynthesis and degradation of mammalian glycosphingolipids
Sandhoff, K., & Kolter, T. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1265 · Cited by 183
Gaucher Disease-Associated Glucocerebrosidases Show Mutation-Dependent Chemical Chaperoning Profiles
Sawkar, A. R., Adamski-Werner, S. L., Cheng, W.-C., Wong, C.-H., Beutler, E., Zimmer, K.-P., & Kelly, J. W. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.09.007 · Cited by 183
Jennemann, R., Sandhoff, R., Wang, S., Kiss, E., Gretz, N., Zuliani, C., Martin-Villalba, A., Jäger, R., Schorle, H., Kenzelmann, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500893102 · Cited by 178
Role of Vibrio cholerae neuraminidase in the function of cholera toxin
Galen, J. E., Ketley, J. M., Fasano, A., Richardson, S. H., Wasserman, S. S., & Kaper, J. B. (1992) · Infection and Immunity · doi:10.1128/iai.60.2.406-415.1992 · Cited by 177
Omega-O-acylceramide, a lipid essential for mammalian survival
Uchida, Y., & Holleran, W. M. (2008) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2008.01.002 · Cited by 177
Platt, F. M., Neises, G. R., Karlsson, G. B., Dwek, R. A., & Butters, T. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47132-3 · Cited by 175
Speak, A. O., Salio, M., Neville, D. C. A., Fontaine, J., Priestman, D. A., Platt, N., Heare, T., Butters, T. D., Dwek, R. A., Trottein, F., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607285104 · Cited by 174
Kihara, A., Mitsutake, S., Mizutani, Y., & Igarashi, Y. (2007) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.03.001 · Cited by 173
Ceramide UDPgalactosyltransferase from myelinating rat brain: purification, cloning, and expression.
Schulte, S., & Stoffel, W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10265 · Cited by 172
Inhibitors of sphingolipid metabolism enzymes
Delgado, A., Casas, J., Llebaria, A., Abad, J. L., & Fabrias, G. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.08.017 · Cited by 170
Norez, C., Noël, S., Wilke, M., Bijvelds, M. J. C., Jorna, H., Melin‐Heschel, P., de Jonge, H. R., & Becq, F. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.03.010 · Cited by 169
CERT and intracellular trafficking of ceramide
Hanada, K., Kumagai, K., Tomishige, N., & Kawano‐Kawada, M. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.01.009 · Cited by 168
Tumor Gangliosides Inhibit the Tumor-Specific Immune Response
McKallip, R., Li, R., & Ladisch, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3718 · Cited by 164
Compain, P., Martin, O. R., Boucheron, C., Godin, G., Yu, L., Ikeda, K., & Asano, N. (2006) · ChemBioChem · doi:10.1002/cbic.200600217 · Cited by 164
Cloning and Characterization of a Novel Human Alkaline Ceramidase
Mao, C., Xu, R., Szulc, Z. M., Bielawska, A., Galadari, S. H., & Obeid, L. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102818200 · Cited by 163
Substrate reduction therapy of glycosphingolipid storage disorders
Aerts, J., Hollak, C., Boot, R., Groener, J., & Maas, M. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0272-5 · Cited by 163
Self-citationEckford, P. D. W., & Sharom, F. J. (2005) · Biochemical Journal · doi:10.1042/bj20050047 · Cited by 157
Therapeutic Applications of Imino Sugars in Lysosomal Storage Disorders
Butters, T. D., Dwek, R. A., & Platt, F. M. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452483 · Cited by 156
Kabayama, K. (2004) · Glycobiology · doi:10.1093/glycob/cwh135 · Cited by 155
Nojiri, H., Stroud, M. R., & Hakomori, S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64355-1 · Cited by 155
The role(s) of Gangliosides in neural differentiation and repair: A perspective
Schengrund, C. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90297-d · Cited by 154
Rijnboutt, S., Aerts, J. M. F. G., Geuze, H. J., Tager, J. M., & Strous, G. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67728-8 · Cited by 153
Self-citationRapid Transbilayer Movement of Ceramides in Phospholipid Vesicles and inHumanErythrocytes
López‐Montero, I., Rodríguez, N., Cribier, S., Pohl, A., Vélez, M., & Devaux, P. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412052200 · Cited by 148
Abe, A., Radin, N. S., Shayman, J. A., Wotring, L. L., Zipkin, R. E., Sivakumar, R., Ruggieri, J. M., Carson, K. G., & Ganem, B. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39895-3 · Cited by 148
Butters, T. D., van den Broek, L. A. G. M., Fleet, G. W. J., Krülle, T. M., Wormald, M. R., Dwek, R. A., & Platt, F. M. (2000) · Tetrahedron Asymmetry · doi:10.1016/s0957-4166(99)00468-1 · Cited by 147
Stanic, A. K., Silva, A. D. D., Park, J., Sriram, V., Ichikawa, S., Hirabyashi, Y., Hayakawa, K., Kaer, L. V., Brutkiewicz, R. R., & Joyce, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0430327100 · Cited by 147
Elevated Levels of M-CSF, sCD14 and IL8 in Type 1 Gaucher Disease
Hollak, C. E. M., Evers, L. M., Aerts, J. M. F. G., & van Oers, M. H. J. (1997) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.1997.0137 · Cited by 147
Self-citationYu, Z., Sawkar, A. R., Whalen, L. J., Wong, C., & Kelly, J. W. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060677i · Cited by 144
van Weely, S., Brandsma, M., Strijland, A., Tager, J. M., & Aerts, J. M. F. G. (1993) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(93)90090-n · Cited by 137
Self-citationZheng, W., Padia, J. K., Urban, D. J., Jadhav, A., Göker-Alpan, Ö., Simeonov, A. M., Goldin, E., Auld, D. S., LaMarca, M. E., Inglese, J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705637104 · Cited by 137
Wennekes, T., van den Berg, R. J. B. H. N., Donker‐Koopman, W. E., van der Marel, G. A., Strijland, A., Aerts, J. M. F. G., & Overkleeft, H. S. (2007) · The Journal of Organic Chemistry · doi:10.1021/jo061280p · Cited by 135
Self-citationSphingosylphosphorylcholine—biological functions and mechanisms of action
zu Heringdorf, D. M. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00154-3 · Cited by 135
Sugar-mimicking glycosidase inhibitors: bioactivity and application
Asano, N. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8522-3 · Cited by 134
Chang, H., Asano, N., Ishii, S., Ichikawa, Y., & Fan, J. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05410.x · Cited by 133
Glycosphingolipids and insulin resistance
Langeveld, M., & Aerts, J. M. F. G. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.03.002 · Cited by 132
Self-citationButters, T. D. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.05.035 · Cited by 131
Analogs of ceramide that inhibit glucocerebroside synthetase in mouse brain
Vunnam, R. R., & Radin, N. S. (1980) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(80)90057-2 · Cited by 129
van Breemen, M. V., de Fost, M., Voerman, J., Laman, J., Boot, R., Maas, M., Hollak, C., Aerts, J., & Rezaee, F. (2007) · Biochimica et Biophysica Acta · doi:10.1016/j.bbadis.2007.04.002 · Cited by 128
Self-citationAlfonso, P., Pampín, S., Estrada, J., Rodríguez-Rey, J. C., Giraldo, P., Sancho, J., & Pocoví, M. (2005) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2005.05.007 · Cited by 127
Crystal Structures of Complexes of N-Butyl- and N-Nonyl-Deoxynojirimycin Bound to Acid β-Glucosidase
Brumshtein, B., Greenblatt, H. M., Butters, T. D., Shaaltiel, Y., Aviezer, D., Silman, I., Futerman, A. H., & Sussman, J. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705005200 · Cited by 126
(Glyco)sphingolipidology: an amazing challenge and opportunity for systems biology
Merrill, A. H., Wang, M. D., Park, M., & Sullards, M. C. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.09.004 · Cited by 125
Lin, H., Sugimoto, Y., Ohsaki, Y., Ninomiya, H., Oka, A., Taniguchi, M., Ida, H., Eto, Y., Ogawa, S., Matsuzaki, Y., et al. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.03.007 · Cited by 125
Mizutani, Y., Kihara, A., & Igarashi, Y. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00274-1 · Cited by 124
The Genesis of a Pandemic Influenza Virus
Russell, C. J., & Webster, R. G. (2005) · Cell · doi:10.1016/j.cell.2005.10.019 · Cited by 124
van Eijk, M., Aten, J., Bijl, N., Ottenhoff, R., van Roomen, C. P. A. A., Dubbelhuis, P. F., Seemann, I., der Vlugt, K. G., Overkleeft, H. S., ARBEENY, C. M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004723 · Cited by 122
Self-citationInhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy
Platt, F. M., Jeyakumar, M., Andersson-Hall, U. K., Priestman, D. A., Dwek, R. A., Butters, T. D., Cox, T. M., Lachmann, R., Hollak, C. E. M., Aerts, J. M. F. G., et al. (2001) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1010335505357 · Cited by 119
Self-citationGlycosphingolipids and drug resistance
Gouazé‐Andersson, V., & Cabot, M. C. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.08.012 · Cited by 119
Integrity and Barrier Function of the Epidermis Critically Depend on Glucosylceramide Synthesis
Jennemann, R., Sandhoff, R., Langbein, L., Kaden, S., Rothermel, U., Gallala, H. D., Sandhoff, K., Wiegandt, H., & Gröne, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m610304200 · Cited by 117
α-1-C-Octyl-1-deoxynojirimycin as a pharmacological chaperone for Gaucher disease
Yu, L., Ikeda, K., Kato, A., Adachi, I., Godin, G., Compain, P., Martin, O. R., & Asano, N. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.08.003 · Cited by 114
Ardail, D., Popa, I., Bodennec, J., Louisot, P., Schmitt, D., & Portoukalian, J. (2003) · Biochemical Journal · doi:10.1042/bj20021834 · Cited by 110
Balreira, A., Gaspar, P., Caiola, D., Chaves, J., Beirão, I. B., Lima, J. L., Azevedo, J. E., & Sá-Miranda, C. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn124 · Cited by 110
Pharmacologic chaperoning as a strategy to treat Gaucher disease
Yu, Z., Sawkar, A. R., & Kelly, J. W. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06042.x · Cited by 105
Diabetes Alters Sphingolipid Metabolism in the Retina
Fox, T. E., Han, X., Kelly, S. L., Merrill, A. H., Martin, R. E., Anderson, R. E., Gardner, T. W., & KESTER, M. A. (2006) · Diabetes · doi:10.2337/db06-0539 · Cited by 105
Sawkar, A. R., Schmitz, M., Zimmer, K., Reczek, D., Edmunds, T., Balch, W. E., & Kelly, J. W. (2006) · ACS Chemical Biology · doi:10.1021/cb600187q · Cited by 102
Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher disease.
Michelakakis, H., Spanou, C., Kondyli, A., Dimitriou, E., van Weely, S., Hollak, C., van Oers, M. V., & Aerts, J. (1996) · Biochimica et Biophysica Acta · doi:10.1016/s0925-4439(96)00056-7 · Cited by 102
Self-citationBosio, A., Binczek, E., Beau, M. M. L., et al. (1996) · Genomics · doi:10.1006/geno.1996.0242 · Cited by 99
Non‐neuronopathic Gaucher disease due to saposin C deficiency
Tylki-Szymańska, A., Czartoryska, B., Vanier, M., Poorthuis, B., Groener, J., Ługowska, A., Millat, G., Vaccaro, A. M., & Jurkiewicz, E. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00899.x · Cited by 98
Klotho-related Protein Is a Novel Cytosolic Neutral β-Glycosylceramidase
Hayashi, Y., Okino, N., Kakuta, Y., Shikanai, T., Tani, M., Narimatsu, H., & Ito, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700832200 · Cited by 98
Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts
JONSSON, L. M. V., Murray, G. J., Sorrell, S. H., Strijland, A., Aerts, J. M. F. G., Ginns, E. I., Barranger, J. A., Tager, J. M., & Schram, A. W. (1987) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1987.tb11008.x · Cited by 94
Self-citationOligomerization and Topology of the Golgi Membrane Protein Glucosylceramide Synthase
Marks, D. L., Wu, K., Paul, P., Kamisaka, Y., Watanabe, R., & Pagano, R. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.451 · Cited by 93
Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases
Aerts, J. M. F. G., Hollak, C. E. M., van Breemen, M. J., Maas, M. M., Groener, J. E. M., & Boot, R. G. (2005) · Acta Paediatrica · doi:10.1111/j.1651-2227.2005.tb02110.x · Cited by 91
Self-citationDoering, T., Proia, R. L., & Sandhoff, K. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00274-4 · Cited by 91
Isofagomine Induced Stabilization of Glucocerebrosidase
Kornhaber, G. J., Tropak, M. B., Maegawa, G. H. B., Tuske, S. J., Coales, S. J., Mahuran, D. J., & Hamuro, Y. (2008) · ChemBioChem · doi:10.1002/cbic.200800249 · Cited by 90
Plasma Membrane-associated Sialidase as a Crucial Regulator of Transmembrane Signalling
Miyagi, T., Wada, T., Yamaguchi, K., Hata, K., & Shiozaki, K. (2008) · The Journal of Biochemistry · doi:10.1093/jb/mvn089 · Cited by 90
Rossmann, M., Schultz‐Heienbrok, R., Behlke, J., Remmel, N., Alings, C., Sandhoff, K., Saenger, W., & Maier, T. (2008) · Structure · doi:10.1016/j.str.2008.02.016 · Cited by 89
The multi-functional role of sphingosylphosphorylcholine
Nixon, G. F., Mathieson, F. A., & Hunter, I. (2007) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.11.001 · Cited by 89
Chapman, T. M., Davies, I. G., Gu, B., Block, T. M., Scopes, D. I. C., Hay, P. A., Courtney, S. M., McNeill, L. A., Schofield, C. J., & Davis, B. G. (2004) · Journal of the American Chemical Society · doi:10.1021/ja043924l · Cited by 86
Functions of sphingolipid metabolism in mammals — Lessons from genetic defects
Sabourdy, F., Kedjouar, B., Sorli, S., Colié, S., Milhas, D., Salma, Y., & Levade, T. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.01.004 · Cited by 81
Transbilayer Movement of Monohexosylsphingolipids in Endoplasmic Reticulum and Golgi Membranes
Buton, X., Hervé, P., Kubelt, J., et al. (2002) · Biochemistry · doi:10.1021/bi020385t · Cited by 79
Mellor, H. R., NOLAN, J., Pickering, L., Wormald, M. R., Platt, F. M., Dwek, R. A., Fleet, G. W. J., & Butters, T. D. (2002) · Biochemical Journal · doi:10.1042/bj20020466 · Cited by 76
Glucocerebrosidase, a lysosomal enzyme that does not undergo oligosaccharide phosphorylation
Aerts, J. M. F. G., Schram, A. W., Strijland, A., van Weely, S., JONSSON, L. M. V., Tager, J. M., Sorrell, S. H., Ginns, E. I., Barranger, J. A., & Murray, G. J. (1988) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(88)90030-x · Cited by 75
Self-citationMolecular imaging of membrane interfaces reveals mode of β-glucosidase activation by saposin C
Alattia, J., Shaw, J. E., Yip, C. M., & Privé, G. G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704998104 · Cited by 73
Accumulation of Glucosylceramide in Murine Testis, Caused by Inhibition of β-Glucosidase 2
Walden, C. M., Sandhoff, R., Chuang, C., Yildiz, Y., Butters, T. D., Dwek, R. A., Platt, F. M., & van der Spoel, A. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702387200 · Cited by 71
Molecular Basis for the p Phenotype
Furukawa, K., Iwamura, K., Uchikawa, M., Sojka, B. N., Wiels, J., Okajima, T., Urano, T., & Furukawa, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000625200 · Cited by 67
CD1 mediated T cell recognition of glycolipids
Zajonc, D. M., & Kronenberg, M. (2007) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2007.09.010 · Cited by 66
Wang, G., Reinkensmeier, G., Zhang, S., Zhou, J., Zhang, L., Zhang, L., Butters, T. D., & Ye, X. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801506m · Cited by 65
Small–molecule therapeutics for the treatment of glycolipid lysosomal storage disorders
Butters, T. D., Mellor, H. R., Narita, K., Dwek, R. A., & Platt, F. M. (2003) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2003.1278 · Cited by 64
Glycosphingolipids in engineered mice: insights into function
Furukawa, K., Tokuda, N., OKUDA, T., Tajima, O., & Furukawa, K. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2004.03.006 · Cited by 62
Yoshizumi, S., Suzuki, S., Hirai, M., Hinokio, Y., Yamada, T., Yamada, T., Tsunoda, U., Aburatani, H., Yamaguchi, K., Miyagi, T., et al. (2007) · Metabolism · doi:10.1016/j.metabol.2006.10.027 · Cited by 61
Sphingolipide – ihre Stoffwechselwege und die Pathobiochemie neurodegenerativer Erkrankungen
Kolter, T., & Sandhoff, K. (1999) · Angewandte Chemie · doi:10.1002/(sici)1521-3757(19990601)111:11<1632::aid-ange1632>3.0.co;2-a · Cited by 61
Roles of plasma membrane-associated sialidase NEU3 in human cancers
Miyagi, T., Wada, T., & Yamaguchi, K. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.09.016 · Cited by 59
Ishibashi, M., Arikawa, J., Okamoto, R., Kawashima, M., Takagi, Y., Ohguchi, K., & Imokawa, G. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000059931.66821.92 · Cited by 54
Lipid-transfer proteins in membrane trafficking at the Golgi complex
Matteis, M. A. D., Campli, A. D., & D’Angelo, G. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.04.004 · Cited by 54
Noël, S., Wilke, M., Bot, A. G. M., de Jonge, H. R., & Becq, F. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.135582 · Cited by 53
van Weely, S., Leeuwen, M. B. V., Jansen, I. D. C., Bruijn, M. A. C. D., Brouwer-Kelder, E. M., Schram, A. W., Sá-Miranda, C., Barranger, J. A., Petersen, E. M., Goldblatt, J., et al. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(91)90066-i · Cited by 53
Self-citationChemical Tools to Investigate Sphingolipid Metabolism and Functions
Delgado, A., Casas, J., Llebaria, A., Abad, J. L., & Fabriàs, G. (2007) · ChemMedChem · doi:10.1002/cmdc.200600195 · Cited by 53
Identification of Active Site Residues in Glucosylceramide Synthase
Marks, D. L., Dominguez, M., Wu, K., & Pagano, R. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102612200 · Cited by 52
Steet, R., Chung, S., Lee, W., Pine, C. W., Do, H., & Kornfeld, S. A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.12.015 · Cited by 49
Li, H., Liu, T., Zhang, Y., Favre, S., Bello, C., Vogel, P., Butters, T. D., Oikonomakos, N. G., Marrot, J., & Blériot, Y. (2008) · ChemBioChem · doi:10.1002/cbic.200700496 · Cited by 49
The glycosylceramidase in the murine intestine. Purification and substrate specificity.
Kobayashi, T., & Suzuki, K. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43343-1 · Cited by 43
Glycolipid depletion in antimicrobial therapy
Svensson, M., Frendéus, B., Butters, T. D., Platt, F. M., Dwek, R. A., & Svanborg, C. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03306.x · Cited by 43
Marks, N., Berg, M. J., Saito, M., & Saito, M. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.066 · Cited by 42
Rational Design and Synthesis of Highly Potent β‐Glucocerebrosidase Inhibitors
Zhu, X., Sheth, K. A., Li, S., Chang, H., & Fan, J. (2005) · Angewandte Chemie · doi:10.1002/ange.200502662 · Cited by 39
A reflection on the early history of glycosphingolipids
Yamakawa, T. (1996) · Glycoconjugate Journal · doi:10.1007/bf00731485 · Cited by 38
New Insights into Glycosphingolipid Functions—Storage, Lipid Rafts, and Translocators
Sillence, D. J. (2007) · International review of cytology · doi:10.1016/s0074-7696(07)62003-8 · Cited by 37
Cited by
Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics
Merrill, A. H. (2011) · Chemical Reviews · doi:10.1021/cr2002917 · Cited by 785
Metabolic features of chronic fatigue syndrome
Naviaux, R. K., Naviaux, J. C., Li, K., Bright, A. T., Alaynick, W. A., Wang, L., Baxter, A., Nathan, N., Anderson, W., & Gordon, E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607571113 · Cited by 391
Van der Lienden, M. J. C., Gaspar, P., Boot, R., Aerts, J. M. F. G., & Van Eijk, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010066 · Cited by 84
Self-citation
Metadata
- Authors
- Wennekes, T., van den Berg, R. J. B. H. N., Boot, R. G., van der Marel, G. A., Overkleeft, H. S., & Aerts, J. M. F. G.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2009-11-04
- Volume
- 48
- Issue
- 47
- Pages
- 8848-8869
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2149949019
- Cited by
- 288
- References
- 211
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.